| 臺大學術典藏 |
2022-02-10T06:29:51Z |
Premature telomere shortening in polymorphonuclear neutrophils from patients with systemic lupus erythematosus is related to the lupus disease activity
|
Wu, C-H; Hsieh, S-C; KO-JEN LI; Lu, M-C; Yu, C-L |
| 臺大學術典藏 |
2022-02-10T06:28:29Z |
Anti-myeloperoxidase antibodies enhance phagocytosis, IL-8 production, and glucose uptake of polymorphonuclear neutrophils rather than anti-proteinase 3 antibodies leading to activation-induced cell death of the neutrophils
|
Hsieh, S C; Yu, H S; Cheng, S H; KO-JEN LI; Lu, M C; Wu, C H; Tsai, C Y; Yu, C L |
| 臺大學術典藏 |
2022-02-10T06:25:12Z |
Comparison of anti-agalactosyl IgG antibodies, rheumatoid factors, and anti-cyclic citrullinated peptide antibodies in the differential diagnosis of rheumatoid arthritis and its mimics
|
Lu, M-C; Hsieh, S-C; Lai, N-S; KO-JEN LI; Wu, C-H; Yu, C-L |
| 臺大學術典藏 |
2022-02-10T06:22:02Z |
Increased multidrug resistance-associated protein activity in mononuclear cells of patients with systemic lupus erythematosus
|
Lu, M-C; Lai, N-S; KO-JEN LI; Hsieh, S-C; Wu, C-H; Yu, C-L |
| 臺大學術典藏 |
2022-02-10T06:16:49Z |
Abnormal in vitro CXCR2 modulation and defective cationic ion transporter expression on polymorphonuclear neutrophils responsible for hyporesponsiveness to IL-8 stimulation in patients with active systemic lupus erythematosus
|
Hsieh, S-C; Wu, T-H; Tsai, C-Y; KO-JEN LI; Lu, M-C; Wu, C-H; Yu, C-L |
| 臺大學術典藏 |
2022-02-10T05:36:39Z |
Abnormal in vitro CXCR2 modulation and defective cationic ion transporter expression on polymorphonuclear neutrophils responsible for hyporesponsiveness to IL-8 stimulation in patients with active systemic lupus erythematosus
|
Hsieh, S-C; Wu, T-H; Tsai, C-Y; KO-JEN LI; Lu, M-C; Wu, C-H; Yu, C-L |
| 國立成功大學 |
2022 |
In vitro activity of cefiderocol, cefepime/enmetazobactam, cefepime/zidebactam, eravacycline, omadacycline, and other comparative agents against carbapenem-non-susceptible Pseudomonas aeruginosa and Acinetobacter baumannii isolates associated from bloodst
|
Liu, P.-Y.;Ko, W.-C.;Lee, W.-S.;Lu, P.-L.;Chen, Y.-H.;Cheng, S.-H.;Lu, M.-C.;Lin, C.-Y.;Wu, T.-S.;Yen, M.-Y.;Wang, L.-S.;Liu, C.-P.;Shao, P.-L.;Lee, Y.-L.;Shi, Z.-Y.;Chen, Y.-S.;Wang, F.-D.;Tseng, S.-H.;Lin, C.-N.;Chen, Y.-H.;Sheng, W.-H.;Lee, C.-M.;Tang, H.-J.;Hsueh, P.-R. |
| 國立成功大學 |
2022 |
Non-susceptibilities to antibiotics against important Gram-negative bacteria, and imipenem-relebactam, meropenem-vaborbactam against carbapenem non-susceptible Enterobacterales and Pseudomonas aeruginosa isolates implicated in complicated intra-abdominal
|
Jean, S.-S.;Lu, M.-C.;Ho, M.-W.;Ko, W.-C.;Hsueh, P.-R.;Group, SMART Taiwan |
| 國立成功大學 |
2022 |
Multicenter surveillance of in vitro activities of cefepime-zidebactam, cefepime-enmetazobactam, omadacycline, eravacycline, and comparator antibiotics against Enterobacterales, Pseudomonas aeruginosa, and Acinetobacter baumannii complex causing bloodstre
|
Jean, S.-S.;Ko, W.-C.;Lu, M.-C.;Lee, W.-S.;Hsueh, P.-R.;Program, on behalf of the SMART |
| 國立成功大學 |
2022 |
Bacteriophages and phage-delivered CRISPR-Cas system as antibacterial therapy
|
Yeh, T.-K.;Jean, S.-S.;Lee, Y.-L.;Lu, M.-C.;Ko, W.-C.;Lin, H.-J.;Liu, P.-Y.;Hsueh, P.-R. |
| 國立成功大學 |
2022 |
Multicenter surveillance of antimicrobial susceptibilities and resistance mechanisms among Enterobacterales species and non-fermenting Gram-negative bacteria from different infection sources in Taiwan from 2016 to 2018
|
Jean, S.-S.;Lee, Y.-L.;Liu, P.-Y.;Lu, M.-C.;Ko, W.-C.;Hsueh, P.-R. |
| 國立成功大學 |
2022 |
Nationwide surveillance of antimicrobial resistance in invasive isolates of Streptococcus pneumoniae in Taiwan from 2017 to 2019
|
Tsai, Y.-T.;Lee, Y.-L.;Lu, M.-C.;Shao, P.-L.;Lu, P.-L.;Cheng, S.-H.;Ko, W.-C.;Lin, C.-Y.;Wu, T.-S.;Yen, M.-Y.;Wang, L.-S.;Liu, C.-P.;Lee, W.-S.;Shi, Z.-Y.;Chen, Y.-S.;Wang, F.-D.;Tseng, S.-H.;Lin, C.-N.;Chen, Y.-H.;Sheng, W.-H.;Lee, C.-M.;Tang, H.-J.;Lin, C.-Y.;Chen, Y.-H.;Hsueh, P.-R. |
| 臺大學術典藏 |
2021-09-27T05:32:42Z |
Nationwide surveillance of antimicrobial resistance in invasive isolates of Streptococcus pneumoniae in Taiwan from 2017 to 2019
|
Tsai Y.-T.; Lee Y.-L.; Lu M.-C.; Shao P.-L.; Lu P.-L.; Cheng S.-H.; Ko W.-C.; Lin C.-Y.; Wu T.-S.; Yen M.-Y.; Wang L.-S.; Liu C.-P.; Lee W.-S.; Shi Z.-Y.; Chen Y.-S.; Wang F.-D.; Tseng S.-H.; Lin C.-N.; Chen Y.-H.; WANG-HUEI SHENG; Lee C.-M.; Tang H.-J.; Lin C.-Y.; Chen Y.-H.; Hsueh P.-R. |
| 臺大學術典藏 |
2021-09-27T05:32:41Z |
In vitro activity of cefiderocol, cefepime/enmetazobactam, cefepime/zidebactam, eravacycline, omadacycline, and other comparative agents against carbapenem-non-susceptible Pseudomonas aeruginosa and Acinetobacter baumannii isolates associated from bloodstream infection in Taiwan between 2018–2020
|
Liu P.-Y.; Ko W.-C.; Lee W.-S.; Lu P.-L.; Chen Y.-H.; Cheng S.-H.; Lu M.-C.; Lin C.-Y.; Wu T.-S.; Yen M.-Y.; Wang L.-S.; Liu C.-P.; Shao P.-L.; Lee Y.-L.; Shi Z.-Y.; Chen Y.-S.; Wang F.-D.; Tseng S.-H.; Lin C.-N.; Chen Y.-H.; WANG-HUEI SHENG; Lee C.-M.; Tang H.-J.; Hsueh P.-R. |
| 臺大學術典藏 |
2021-09-27T05:32:39Z |
Antimicrobial susceptibility of bacteremic vancomycin-resistant Enterococcus faecium to eravacycline, omadacycline, lipoglycopeptides, and other comparator antibiotics: Results from the 2019–2020 Nationwide Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART)
|
Tsai H.-Y.; Lee Y.-L.; Liu P.-Y.; Lu M.-C.; Shao P.-L.; Lu P.-L.; Cheng S.-H.; Ko W.-C.; Lin C.-Y.; Wu T.-S.; Yen M.-Y.; Wang L.-S.; Liu C.-P.; Lee W.-S.; Shi Z.-Y.; Chen Y.-S.; Wang F.-D.; Tseng S.-H.; Chen Y.-H.; WANG-HUEI SHENG; Lee C.-M.; Chen Y.-H.; Liao C.-H.; Hsueh P.-R. |
| 臺大學術典藏 |
2021-09-27T05:32:37Z |
In-vitro activity of cefiderocol, cefepime/zidebactam, cefepime/enmetazobactam, omadacycline, eravacycline and other comparative agents against carbapenem-nonsusceptible Enterobacterales: results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) in 2017–2020
|
Lee Y.-L.; Ko W.-C.; Lee W.-S.; Lu P.-L.; Chen Y.-H.; Cheng S.-H.; Lu M.-C.; Lin C.-Y.; Wu T.-S.; Yen M.-Y.; Wang L.-S.; Liu C.-P.; Shao P.-L.; Shi Z.-Y.; Chen Y.-S.; Wang F.-D.; Tseng S.-H.; Lin C.-N.; Chen Y.-H.; WANG-HUEI SHENG; Lee C.-M.; Tang H.-J.; Hsueh P.-R. |
| 臺大學術典藏 |
2021-09-27T05:32:37Z |
National surveillance of antimicrobial susceptibilities to dalbavancin, telavancin, tedizolid, eravacycline, omadacycline and other comparator antibiotics and serotype distribution of invasive Streptococcus pneumoniae isolates in adults: results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) programme in 2017–2020
|
Chien Y.-C.; Lee Y.-L.; Liu P.-Y.; Lu M.-C.; Shao P.-L.; Lu P.-L.; Cheng S.-H.; Lin C.-Y.; Wu T.-S.; Yen M.-Y.; Wang L.-S.; Liu C.-P.; Lee W.-S.; Shi Z.-Y.; Chen Y.-S.; Wang F.-D.; Tseng S.-H.; Chen Y.-H.; WANG-HUEI SHENG; Lee C.-M.; Chen Y.-H.; Ko W.-C.; Hsueh P.-R. |
| 臺大學術典藏 |
2021-09-14T02:45:52Z |
Multicenter evaluation of two chemiluminescence and three lateral flow immunoassays for the diagnosis of COVID-19 and assessment of antibody dynamic responses to SARS-CoV-2 in Taiwan
|
Chen S.-Y.; Lee Y.-L.; Lin Y.-C.; Lee N.-Y.; Liao C.-H.; Hung Y.-P.; Lu M.-C.; JHONG-LIN WU; Tseng W.-P.; Lin C.-H.; Chung M.-Y.; Kang C.-M.; Lee Y.-F.; Lee T.-F.; Cheng C.-Y.; Chen C.-P.; Huang C.-H.; Liu C.-E.; Cheng S.-H.; Ko W.-C.; Hsueh P.-R.; Chen S.-C. |
| 臺大學術典藏 |
2021-07-17T00:58:57Z |
New secondary metabolite with cytotoxicity from spawning soft coral Asterospicularia laurae in Taiwan
|
Su J.-H;Liu C.-I;Lu M.-C;Chang C.-I;Hsieh M.-Y;Lin Y.-C;Dai C.-F;Zhang Y.-H;Lin Z.-Y;Lin Y.-S.; Su J.-H; Liu C.-I; Lu M.-C; Chang C.-I; Hsieh M.-Y; Lin Y.-C; Dai C.-F; Zhang Y.-H; Lin Z.-Y; Lin Y.-S.; CHANG-FENG DAI |
| 臺大學術典藏 |
2021-07-17T00:58:37Z |
Interaction among controlling factors on riverine din export in small mountainous rivers of taiwan: Inseparable human-landscape system
|
Lee W.-S;Huang J.-C;Chang C.-T;Chan S.-C;Liou Y.-S;Liao C.-S;Lee L.-C;Lee J.-Y;Shih Y.-T;Lu M.-C;Chen P.-H.; Lee W.-S; JR-CHUAN HUANG et al. |
| 臺大學術典藏 |
2021-05-07T08:04:40Z |
Multicenter evaluation of two chemiluminescence and three lateral flow immunoassays for the diagnosis of COVID-19 and assessment of antibody dynamic responses to SARS-CoV-2 in Taiwan
|
Chen S.-Y.;Lee Y.-L.;Lin Y.-C.;Lee N.-Y.;Liao C.-H.;Hung Y.-P.;Lu M.-C.;Wu J.-L.;Tseng W.-P.;Chien-Hao Lin;Chung M.-Y.;Kang C.-M.;Lee Y.-F.;Lee T.-F.;Cheng C.-Y.;Chen C.-P.;Huang C.-H.;Liu C.-E.;Cheng S.-H.;Ko W.-C.;Hsueh P.-R.;Chen S.-C.; Chen S.-Y.; Lee Y.-L.; Lin Y.-C.; Lee N.-Y.; Liao C.-H.; Hung Y.-P.; Lu M.-C.; Wu J.-L.; Tseng W.-P.; CHIEN-HAO LIN; Chung M.-Y.; Kang C.-M.; Lee Y.-F.; Lee T.-F.; Cheng C.-Y.; Chen C.-P.; Huang C.-H.; Liu C.-E.; Cheng S.-H.; Ko W.-C.; Hsueh P.-R.; Chen S.-C. |
| 臺大學術典藏 |
2021-05-07T06:54:30Z |
Multicenter evaluation of two chemiluminescence and three lateral flow immunoassays for the diagnosis of COVID-19 and assessment of antibody dynamic responses to SARS-CoV-2 in Taiwan
|
Chen S.-Y.;Lee Y.-L.;Lin Y.-C.;Lee N.-Y.;Liao C.-H.;Hung Y.-P.;Lu M.-C.;Wu J.-L.;Wen-Pin Tseng;Lin C.-H.;Chung M.-Y.;Kang C.-M.;Lee Y.-F.;Lee T.-F.;Cheng C.-Y.;Chen C.-P.;Huang C.-H.;Liu C.-E.;Cheng S.-H.;Ko W.-C.;Hsueh P.-R.;Chen S.-C.; Chen S.-Y.; Lee Y.-L.; Lin Y.-C.; Lee N.-Y.; Liao C.-H.; Hung Y.-P.; Lu M.-C.; Wu J.-L.; WEN-PIN TSENG; Lin C.-H.; Chung M.-Y.; Kang C.-M.; Lee Y.-F.; Lee T.-F.; Cheng C.-Y.; Chen C.-P.; Huang C.-H.; Liu C.-E.; Cheng S.-H.; Ko W.-C.; Hsueh P.-R.; Chen S.-C. |
| 臺大學術典藏 |
2021-05-06T08:25:58Z |
In vitro activity of ceftazidime–avibactam, ceftolozane–tazobactam, and other comparable agents against clinically important Gram-negative bacilli: Results from the 2017 surveillance of multicenter antimicrobial resistance in Taiwan (SMART)
|
Jean S.-S.; Lu M.-C.; Shi Z.-Y.; Tseng S.-H.; Wu T.-S.; Lu P.-L.; PEI-LAN SHAO; Ko W.-C.; Wang F.-D.; Hsueh P.-R. |
| 臺大學術典藏 |
2021-05-06T08:25:57Z |
Nationwide surveillance of antimicrobial resistance among clinically important Gram-negative bacteria, with an emphasis on carbapenems and colistin: Results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) in 2018
|
Lee Y.-L.;Lu M.-C.;Pei-Lan Shao;Lu P.-L.;Chen Y.-H.;Cheng S.-H.;Ko W.-C.;Lin C.-Y.;Wu T.-S.;Yen M.-Y.;Wang L.-S.;Liu C.-P.;Lee W.-S.;Shi Z.-Y.;Chen Y.-S.;Wang F.-D.;Tseng S.-H.;Lin C.-N.;Chen Y.-H.;Sheng W.-H.;Lee C.-M.;Liao M.-H.;Hsueh P.-R.; Lee Y.-L.; Lu M.-C.; PEI-LAN SHAO; Lu P.-L.; Chen Y.-H.; Cheng S.-H.; Ko W.-C.; Lin C.-Y.; Wu T.-S.; Yen M.-Y.; Wang L.-S.; Liu C.-P.; Lee W.-S.; Shi Z.-Y.; Chen Y.-S.; Wang F.-D.; Tseng S.-H.; Lin C.-N.; Chen Y.-H.; Sheng W.-H.; Lee C.-M.; Liao M.-H.; Hsueh P.-R. |
| 臺大學術典藏 |
2021-05-06T08:25:56Z |
National surveillance of antimicrobial susceptibility of bacteremic gram-negative bacteria with emphasis on community-acquired resistant isolates: Report from the 2019 surveillance of multicenter antimicrobial resistance in Taiwan (SMART)
|
Liu P.-Y.;Lee Y.-L.;Lu M.-C.;Pei-Lan Shao;Lu P.-L.;Chen Y.-H.;Cheng S.-H.;Ko W.-C.;Lin C.-Y.;Wu T.-S.;Yen M.-Y.;Wang L.-S.;Liu C.-P.;Lee W.-S.;Chen Y.-S.;Wang F.-D.;Tseng S.-H.;Lin C.-N.;Tang H.-J.;Chen Y.-H.;Sheng W.-H.;Lee C.-M.;Liao M.-H.;Hsueh P.-R.; Liu P.-Y.; Lee Y.-L.; Lu M.-C.; PEI-LAN SHAO; Lu P.-L.; Chen Y.-H.; Cheng S.-H.; Ko W.-C.; Lin C.-Y.; Wu T.-S.; Yen M.-Y.; Wang L.-S.; Liu C.-P.; Lee W.-S.; Chen Y.-S.; Wang F.-D.; Tseng S.-H.; Lin C.-N.; Tang H.-J.; Chen Y.-H.; Sheng W.-H.; Lee C.-M.; Liao M.-H.; Hsueh P.-R. |
